Aldeyra Therapeutics, Inc. Skyrocketed
Thu, Mar 19, 2026 at 07:25 PM
Aldeyra Therapeutics, Inc. (ALDX:NASDAQ) rocketted at $1.83, a gain of 28.9%. The stock appeared on our News Catalysts scanner on Wed, Mar 18, 2026 at 03:56 PM in the 'BIOTECH' category. From Thu, Mar 05, 2026, the stock recorded 50.00% Up Days and 45.45% Green Days
About Aldeyra Therapeutics, Inc. (ALDX:NASDAQ)
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
Top 10 Gainers:
- Serina Therapeutics, Inc. (SER:NYSEMKT), 93.75%
- Webus International Limited (WETO:NASDAQ), 64.64%
- Linkers Industries Limited (LNKS:NASDAQ), 51.36%
- Duluth Holdings Inc. (DLTH:NASDAQ), 44.7%
- AEye, Inc. (LIDR:NASDAQ), 38.5%
- SUNation Energy Inc. (SUNE:NASDAQ), 37.5%
- China Natural Resources, Inc. (CHNR:NASDAQ), 32.12%
- LanzaTech Global, Inc. (LNZA:NASDAQ), 31.87%
- Envela Corporation (ELA:NYSEMKT), 31.18%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 28.87%